307 related articles for article (PubMed ID: 18577151)
1. Insulin glargine: cornerstone treatment for type 2 diabetes patients. Introduction.
Garg SK
Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():1-4. PubMed ID: 18577151
[No Abstract] [Full Text] [Related]
2. Preoperative hypoglycemia in a patient receiving insulin detemir.
Olson RP; Bethel MA; Lien L
Anesth Analg; 2009 Jun; 108(6):1836-8. PubMed ID: 19448209
[TBL] [Abstract][Full Text] [Related]
3. Lower severe hypoglycemia risk: insulin glargine versus NPH insulin in type 2 diabetes.
Dailey G; Strange P
Am J Manag Care; 2008 Jan; 14(1):25-30. PubMed ID: 18197742
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials.
Bazzano LA; Lee LJ; Shi L; Reynolds K; Jackson JA; Fonseca V
Diabet Med; 2008 Aug; 25(8):924-32. PubMed ID: 18959605
[TBL] [Abstract][Full Text] [Related]
5. How do detemir and glargine compare when added to oral agents in insulin-naïve patients with type 2 diabetes mellitus?
Koenen C
Nat Clin Pract Endocrinol Metab; 2008 Oct; 4(10):E1. PubMed ID: 18806804
[No Abstract] [Full Text] [Related]
6. Achieve better glucose control for your hospitalized patients.
Woolever DR
J Fam Pract; 2008 Dec; 57(12):782-8. PubMed ID: 19080760
[No Abstract] [Full Text] [Related]
7. [Syndrome of chronic overdose of insulin and hypoglycemic sulfanilamide drugs].
Arzumetova DS; Saburenko MB; Shagazatova BKh; Zabikhodzhaeva GZ
Klin Med (Mosk); 1989 Apr; 67(4):99-101. PubMed ID: 2666739
[TBL] [Abstract][Full Text] [Related]
8. Insulin and oral hypoglycemic agents should not be used in combination in the treatment of type 2 diabetes.
Westphal SA; Palumbo PJ
Arch Intern Med; 2003 Aug 11-25; 163(15):1783-5; discussion 1785. PubMed ID: 12912711
[No Abstract] [Full Text] [Related]
9. When 'look-alikes' and 'sound-alikes' don't act alike.
Lilley LL; Guanci R
Am J Nurs; 1997 Sep; 97(9):12-4. PubMed ID: 9311329
[No Abstract] [Full Text] [Related]
10. Overcoming barriers to insulin replacement.
Kuritzky L
J Fam Pract; 2009 Aug; 58(8 Suppl):S25-31. PubMed ID: 19679028
[No Abstract] [Full Text] [Related]
11. Insulin glargine (Lantus) and cancer risk.
Med Lett Drugs Ther; 2009 Aug; 51(1319):67-8. PubMed ID: 19696708
[No Abstract] [Full Text] [Related]
12. Insulin therapy in elderly patients with type 2 diabetes: the role of insulin glargine.
Janka HU
Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():35-41. PubMed ID: 18577155
[TBL] [Abstract][Full Text] [Related]
13. Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.
Bakiner O; Ertorer ME; Bozkirli E; Tutuncu NB; Demirag NG
Acta Diabetol; 2009 Mar; 46(1):63-5. PubMed ID: 18825302
[TBL] [Abstract][Full Text] [Related]
14. Transitioning and adjusting insulin analog therapy in elderly patients.
Bray B
Consult Pharm; 2008 Apr; 23 Suppl B():17-23. PubMed ID: 18540789
[TBL] [Abstract][Full Text] [Related]
15. Basal insulin glargine vs prandial insulin lispro in type 2 diabetes.
Oliveira JH; Kazda C; Simpson A; Jackson JA; Heine RJ
Lancet; 2008 Aug; 372(9636):371-2; author reply 372. PubMed ID: 18675683
[No Abstract] [Full Text] [Related]
16. Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study.
Hermansen K; Dornhorst A; Sreenan S
Curr Med Res Opin; 2009 Nov; 25(11):2601-8. PubMed ID: 19739940
[TBL] [Abstract][Full Text] [Related]
17. [Lispro mixed insulins in type 2 diabetes. Preventing postprandial insulin rise].
MMW Fortschr Med; 2000 Jul; 142(28-29):58-9. PubMed ID: 10959169
[No Abstract] [Full Text] [Related]
18. [Evaluating the feature of hypoglycemia detected by continuous glucose monitoring system during temporary continuous subcutaneous insulin infusion in type 2 diabetes patients].
Li M; Zhou J; Bo YQ; Lu W; Jia WP; Xiang KS
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1679-82. PubMed ID: 19024537
[TBL] [Abstract][Full Text] [Related]
19. Comparison of glycaemic control in patients with Type 2 diabetes on basal insulin and fixed combination oral antidiabetic treatment: results of a pilot study.
De Mattia G; Laurenti O; Moretti A
Acta Diabetol; 2009 Mar; 46(1):67-73. PubMed ID: 19030772
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic strategies in type 2 diabetes].
Waeber G; Vollenweider P; Ruiz J
Praxis (Bern 1994); 2001 Dec; 90(51-52):2245-54. PubMed ID: 11820166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
